Zimmer Biomet Holdings ZBH
NYSE ZBH
$94.61 +0.39 (+0.41%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zimmer Biomet Holdings (ZBH) Profit After Tax Growth (3y) (2012 - 2026)

Analysis

Zimmer Biomet Holdings (ZBH) Profit After Tax Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Abbott Laboratories 183.54 Bn 177.94 Bn 7.27 Bn -12.28%
2 Intuitive Surgical 124.25 Bn 119.03 Bn 1.96 Bn 21.98%
3 Medtronic 118.34 Bn 109.52 Bn 6.34 Bn 22.89%
4 Stryker 106.50 Bn 103.03 Bn 4.50 Bn 20.02%
5 Boston Scientific 66.56 Bn 66.02 Bn 3.85 Bn 49.66%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -7.65%
7 Alcon 33.98 Bn 32.52 Bn 1.68 Bn -
8 Dexcom 32.07 Bn 30.12 Bn 830.00 Mn 29.05%
9 Steris 21.10 Bn 20.61 Bn 684.20 Mn 15.46%
10 Zimmer Biomet Holdings 18.27 Bn 17.86 Bn 1.54 Bn -1.66%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.66%
Mar 31, 2026 0.78%
Dec 31, 2025 45.17%
Sep 30, 2025 5.99%
Jun 30, 2025 -0.13%
Mar 31, 2025 35.62%
Dec 31, 2024 85.56%
Sep 30, 2024 15.34%
Jun 30, 2024 18.85%
Mar 31, 2024 -4.45%
Dec 31, 2023 7.94%
Sep 30, 2023 -12.87%
Jun 30, 2023 44.36%
Mar 31, 2023 34.94%
Dec 31, 2022 -34.00%
Sep 30, 2022 -23.34%
Jun 30, 2022 4.82%
Mar 31, 2022 -33.25%
Dec 31, 2021 60.70%
Sep 30, 2021 0.04%